Infinity Pharmaceuticals CEO Adelene Perkins' 2020 pay jumps 63% to $2.7M
Infinity Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 26, 2021
Infinity Pharmaceuticals reported fiscal year 2020 executive compensation information on April 26, 2021.
In 2020, three executives at Infinity Pharmaceuticals received on average a compensation package of $2M, a 71% increase compared to previous year.
Average pay of disclosed executives at Infinity Pharmaceuticals
Adelene Q. Perkins, Chief Executive Officer, received $2.7M in total, which increased by 63% compared to 2019. 51% of Perkins' compensation, or $1.4M, was in option awards. Perkins also received $448K in non-equity incentive plan, $690K in salary, $194K in stock awards, as well as $11K in other compensation.
Lawrence E. Bloch, President, received a compensation package of $1.8M, which increased by 56% compared to previous year. 53% of the compensation package, or $967K, was in option awards.
Seth A. Tasker, Secretary, earned $1.4M in 2020, a 120% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2021.